Kathryn Ruddy

77PUBLICATIONS
535CO-AUTHORS
Predictive and prognostic markersChemotherapyMolecular targetsWomen's studies (incl. girls' studies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Jun 17, 2026
Factors Associated With Alcohol Intake in Patients With Newly Diagnosed Breast Cancer.

|May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain.

|Apr 29, 2026
Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

|Mar 03, 2026
Nationwide Mammographic Screening Among a Large Population of Underserved Subgroups.

Elizabeth J Cathcart-Rake, Viengneesee Thao, Jennifer Le-Rademacher

|Feb 13, 2026
Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study.

Pankaj Gupta, Kalpna Gupta, Travis Dockter

|Jan 26, 2026
Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Bradley J Stish, Gina L Mazza, Jones T Nauseef

Pageof 13

Frequent Collaborators

27 joint publications

Ann Partridge

13 joint publications

Shoshana Rosenberg

10 joint publications

Lidia Schapira

9 joint publications

Virginia F Borges